Speaker illustration

Associate Professor Marek Postula

Medical University of Warsaw, Warsaw (Poland)

Member of:

European Society of Cardiology

Healthy aging and modern prevention enthusiast; Consultant Cardiologist; Sport cardiologist; Internal Medicine Specialist; Chief of Pharmacogenomic Lab at the Medical University of Warsaw; I-COMET team co-founder; Chief of the Pharmacogenomic Laboratory at the Department of Experimental and Clinical Pharmacology, Medical University of Warsaw; EMpagliflozin and daPAgliflozin in patients hospiTalized for acute decompensated Heart failure (EMPATHY trial)- managing director and co-PI,

Thrombosis-related miR-16-5p predicts the disease severity in patients hospitalised for COVID-19

Event: ESC Congress 2022

Topic: Thrombosis, Bleeding

Session: Cardiovascular aspects of COVID and long-COVID

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb